MG-Brio Syrup

MG Brio Syrup Get Back the Zestfulness of Life

Composition:
Syrup - Omega-3-Fatty Acid 600 mg + EPA 250 mg + DHA 190 mg Syrup Drops - Each 1 ml Contains : Omega-3-Fatty Acid 500 mg + EPA 180 mg + DHA 120 mg Syrup

American Heart Association in the Management of Hypertriglyceridemia

By Dr. Peter W.F. Wilson in the et.al published on August 19th ,2019. This study concludes that 2-4 gms of Omega-3 Fatty Acid per day is recommended by AHA for patients with hypertriglyceridemia have shown considerable improvement.

BDA (British Dietetic Association), United Kingdom

Recommends Fish in a daily diet of approximately750 gms every day, which can be supplemented through Omega-3 Fatty Acid preparation.

JAMA (Journal of American Medical Association)

Report on Asthma published on August 2nd, 2023. By Dr. Emily Haris who concludes that Omega-3 Fatty Acid improves Lung function, decreases the severity of Bronchial Asthma and makes Asthma control easier.

JAMA (Journal of American Medical Association)

Report on Brain and Neurological health published in the year 2014. By Dr.H.M. Chandola and Dr. Ila Tanna, Omega-3 Fatty Acid plays a critical role in the development and function of CNS, further research established that EPA, DHA, and Omega-3Fatty Acid, ALA have greater connection with the CNS and major depressive disorder.

Neuromolecular medicine 2008

On the Neurological Benefit of Omega-3 Fatty Acid. By Dr. S.C.Dyell et.al concludes that CNS is highly enriched in long-chain PUFA of the Omega-6 and Omega-3 series potential benefit of long-chain PUFA has been established.

NCBI study conducted by the National Library on Medicine on the topic of ARRHYTHMIA.

The above study published in the month of October, 2023 says that Post Operative Atrial Fibrillation(POAF) is a common complication in the acute care period following Coronary Artery Bi-pass Grafting(CABG) Morbidity and Mortality can be considerably reduced by Omega-3 Fatty Acid.

AHA (American Heart Association) on Coronary Heart Disease (CHD)

Report published in November 2002 says that CHD mortality rates have come down drastically after the usage of Omega-3 Fatty Acid

Annals of Internal Medicine on Prophylaxis of Atherosclerosis with MarineOmega-3 Fatty Acid

Dr.Clenens Von Schacky concluded that there is a significant correlation between Omega-3 Fatty Acid and Mortality / Morbidity from Cardio-vascular disease.

There is a reduction in platelet responsiveness, lowering of blood lipids, improvement of blood flow and other values implicated in the pathogenesis of Atherosclerosis.

The study concludes that Omega-3 Fatty acids have larger prophylactic potential.

Journal of Pharmaceutical Research International 2022, Volume 34 – pages 51-62

A pharmaconeutrient, Omega-3 Fatty Acid reduces the inflammatory response of Cancer Patients. The Cyclooxygenase-2 expression is suppressed by the Omega-3 Fatty Acid and reduces the growth of tumour cells. Mental wellness is a significant lifestyle aspect that the Cancer Patient cannot maintain.